2 studies found for:    22547592 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Not yet recruiting Optimal Sequencing of Pembrolizumab (MK-3475) and Standard Platinum-based Chemotherapy in First-Line NSCLC
Condition: Non-Small Cell Lung Cancer
Interventions: Drug: MK-3475;   Drug: Carboplatin;   Drug: Paclitaxel;   Drug: Pemetrexed
2 Recruiting Small Cell Lung Carcinoma Trial With Nivolumab and IpiliMUmab in LImited Disease
Conditions: Limited Stage Small Cell Lung Cancer;   Small Cell Lung Cancer
Interventions: Drug: Ipilimumab;   Drug: Nivolumab

Indicates status has not been verified in more than two years